en

PRODUCT DETAIL

Jylamvo 2 mg/ml perorálny roztok

Code 3713C
MA number EU/1/17/1172/001
Product Form: sol por 1x60 ml/120 mg (fľ.jant.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Therakind (Europe) Limited, Ireland
Therapeutic Class: 29 - ANTIRHEUMATICA, ANTIPHLOGISTICA, ANTIURATICA
ATC:
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01B ANTIMETABOLITES
L01BA Folic acid analogues
L01BA01 Methotrexate
Shelf life: 18
Container: amber glass bottle
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10(3) hybrid application
MA issued: 29.03.2017
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 25.01.2022
eu-flag.png sk-flag.png